Hardman

Hardman & Co Video Event | Shield Therapeutics plc - Investor Forum

Retrieved on: 
Thursday, August 12, 2021
Hardman & Co., Hardman, Therapy, Knowledge, Financial Conduct Authority, Directive 2014/65/EU, Companies House, FCA, YouTube, Q&A, Shield, Research, Forum, NEWS, II, Security (finance)

We are delighted to announce that Shield Therapeutics plc will be presenting at our next Investor Forum on Thursday 23 September at 5:00pm.

Key Points: 
  • We are delighted to announce that Shield Therapeutics plc will be presenting at our next Investor Forum on Thursday 23 September at 5:00pm.
  • The Investor Forum connects investors with companies looking for capital.
  • Outside the US, the strategy is to use distribution and commercialisation partners in return for royalties and sales milestones.
  • A recording of the webinar will be available on the Hardman & Co website shortly after the event for those cannot attend the live presentation.

Hardman & Co Video Event | Diurnal Group plc - Investor Forum

Retrieved on: 
Thursday, August 12, 2021
Hardman & Co., Hardman, Knowledge, Financial Conduct Authority, Directive 2014/65/EU, Communication, Companies House, FCA, YouTube, Q&A, Research, Forum, NEWS, II, Pharmaceutical industry, Security (finance)

We are delighted to announce that Diurnal Group plc will be presenting at our next Investor Forum on Thursday 23 September at 5:00pm.

Key Points: 
  • We are delighted to announce that Diurnal Group plc will be presenting at our next Investor Forum on Thursday 23 September at 5:00pm.
  • The Forum is being hosted by Hardman & Co and investors can register to attend via this link: https://hardman-co.com/p/49CL-HU2/join-our-webinar
    Diurnal Group plc is a European, UK-headquartered, specialty pharma company targeting patient needs in chronic, potentially life-threatening, endocrine (hormonal) diseases.
  • This webinar represents a key communication channel for investors to keep up to date with the company's strategy and progress.
  • A recording of the webinar will be available on the Hardman & Co website shortly after the event for those cannot attend the live presentation.

Hardman & Co Video Event | Incanthera plc - Investor Forum

Retrieved on: 
Thursday, August 12, 2021
Hardman & Co., Hardman, Knowledge, Financial Conduct Authority, Directive 2014/65/EU, Companies House, FCA, YouTube, Q&A, Research, Forum, NEWS, II, Dermatology, Security (finance)

We are delighted to announce that Incanthera plc will be presenting at our next Investor Forum on Thursday 23 September at 5:00pm.

Key Points: 
  • We are delighted to announce that Incanthera plc will be presenting at our next Investor Forum on Thursday 23 September at 5:00pm.
  • The Investor Forum connects investors with companies looking for capital.
  • The Forum is being hosted by Hardman & Co and investors can register to attend via this link: https://hardman-co.com/p/49CL-HU2/join-our-webinar
    Incanthera plc is a UK-based specialist oncology and dermatology company.
  • A recording of the webinar will be available on the Hardman & Co website shortly after the event for those cannot attend the live presentation.

Hardman & Co Research: Q&A with Mark Thomas on Fidelity Japan Trust (FJV): Fund of the rising returns

Retrieved on: 
Friday, July 30, 2021
Hardman & Co., Hardman

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

Hardman & Co Research: Volta Finance Limited (VTA): Yield (10%, covered and growing) + capital growth

Retrieved on: 
Wednesday, July 28, 2021
Hardman & Co., Hardman

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

Hardman & Co Research: Fidelity Special Values Plc (Initiation of Coverage) - FSV: consistent contrarianism adds special value

Retrieved on: 
Tuesday, July 27, 2021
Hardman & Co., Hardman

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

Hardman & Co Research: CyanConnode (CYAN): Further contract award in Thailand

Retrieved on: 
Friday, July 16, 2021
Hardman & Co., Hardman

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

Hardman & Co Research: City of London Investment Group (CLIG): It's an all-time high

Retrieved on: 
Friday, July 16, 2021
Hardman & Co., Hardman

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

Hardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream

Retrieved on: 
Wednesday, July 14, 2021
Hardman & Co., Hardman

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.

Hardman & Co Research: Fidelity Japan Trust Plc (Initiation of Coverage) - FJV: fund of the rising returns

Retrieved on: 
Tuesday, July 13, 2021
Hardman & Co., Hardman

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.

Key Points: 
  • About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities.
  • Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge.
  • Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services.
  • Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843.